Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Rosuvastatin pharmacokinetics in morbid obese patients before and after Roux-en-Y gastric bypass surgery

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: WU, Hsin-Fang (University of California-San Francisco, University of California-San Francisco, San Francisco, United States)
  • Co-author(s): Hsin-Fang Wu: Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, United States
    Hideaki Okochi: Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, United States
    Leslie Benet: Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, United States
  • Abstract:

    Backgrounds

    Morbidly obese patients frequently present with cholesterol disorders, which are often treated with statins. A previous study demonstrated that the majority of patients undergoing roux-en-Y gastric bypass (RYGB) showed increased atorvastatin acid systemic exposure after surgery.

    Aims

    This study examined the effect of RYGB on rosuvastatin

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses